UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Weaver Consulting Group

Weaver Consulting Group trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 454 shares of the healthcare conglomerate’s stock after selling 42 shares during the period. Weaver Consulting Group’s holdings in UnitedHealth Group were worth $265,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group during the third quarter worth $27,000. Macroview Investment Management LLC boosted its stake in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $31,000. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. Finally, Signature Resources Capital Management LLC raised its stake in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 5.2 %

Shares of NYSE UNH opened at $578.97 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $587.48 and its two-hundred day moving average is $558.34. The firm has a market cap of $532.81 billion, a price-to-earnings ratio of 37.72, a PEG ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the company posted $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.45%. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Finally, KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $625.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.